Sign in

NCT07659028Not yet recruiting

Human Pilot Study for the Investigation of the Role of Bilberry and Olive Bioactives on Oxidative Stress Parameters and Inflammatory Markers.

A Blinded Placebo-controlled Human Pilot Study for the Investigation of the Role of Bilberry and Olive Bioactives on Oxidative Stress Parameters and Inflammatory Markers. Relevance in European Population

Source: ClinicalTrials.gov · Last updated 22 Jun 2026

Brief summary (registry, in English)

Numerous plant-based foods contain bioactive compounds, in particular polyphenols, which have antioxidant, anti-inflammatory, and metabolic regulatory effects. These so-called food bioactives (FB) are converted in the human organism, in particular by the gut microbiota and microsomal (liver/intestinal) metabolism, into numerous metabolites, which often represent the actual biologically active molecules. As part of the European HORIZON-MSCA Doctoral Network "BioTransform," two such food models are being studied as examples: 1. Olive products (Olea europaea L.) - representative of the Mediterranean diet, rich in secoiridoids and phenylethanols (especially hydroxytyrosol and tyrosol). 2. Bilberry /blueberry (Vaccinium myrtillus L.) - representative of the Central European diet, rich in anthocyanosides. Two parallel human intervention studies will be conducted, one in Graz (WP1, DC5) and one in Athens (WP1, DC3). These pilot studies will generate biological samples (blood, urine, stool) and investigate the extent to which taking these standardized dietary supplements influences glucose metabolism and markers of oxidative stress and low-grade inflammation.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
9 Jun 2026
Start date
1 Jul 2026
Primary completion date
1 Jul 2029
Lead sponsor
National and Kapodistrian University of Athens
Diseases
Obesity
NCT number
NCT07659028

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Jul 2026 to the primary completion date, 1 Jul 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic gastrointestinal, inflammatory or metabolic diseases
  • Acute infection during the past month

Other

  • No signed informed consent
  • Supplementation or probiotic usage in the past 8 weeks
  • Alcohol misuse
  • Pregnancy or breastfeeding

Who the study is looking for

  • 30-50 years old,
  • BMI\> 25 kg/m2
  • prediabetic stage
  • hsCRP\> 2mg/ L
  • HbA1c 5,7-6,4%
  • Impaired fasting glucose (IFG)
  • Caucasian

Age in the registry: 30 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Laiko Hospital
Coordinator of this site? Confirm its status
AthensGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.